Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025
COPENHAGEN, Denmark, May 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest...
Pharmaceutical
Optimi Health Obtains U.S. FDA Drug Establishment Registration
The Company is now recognized by the U.S. FDA to support the cross-border supply of GMP MDMA and psilocybin to...
Cosmo Highlights Strategic AI and GI Innovation Agenda at Digestive Disease Week(R) 2025
Dublin, Ireland--(Newsfile Corp. - May 5, 2025) - Cosmo is attending this year’s Digestive Disease Week® (DDW), held in San...
IBA launches QUASAR® GRID3D Advantage Image Distortion Analysis System
New standard in the Quality Assurance of image distortion for MR guided radiation therapy and MR simulation in planning Louvain-la-Neuve, Belgium,...
ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
The company will showcase innovations designed to optimize the oncology care workflow and enable improved patient outcomes CHICAGO--(BUSINESS WIRE)--GE HealthCare...
Life Science Analytics Market worth $68.81 billion by 2030 11.4% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Life Science Analytics Market , valued at US$35.69 billion in 2024,...
Virgo launches EndoML, a state-of-the-art AI development platform for gastroenterologists and pharmaceutical researchers, at DDW 2025
SAN DIEGO, May 2, 2025 /PRNewswire/ -- Virgo Surgical Video Solutions, Inc., a leader in endoscopic AI technologies, today announced...
Cosmo Announces EU MDR Certification for Endovision’s Cerebro, expanding its real-time AI ecosystem
Dublin, Ireland--(Newsfile Corp. - May 2, 2025) - Cosmo is excited to announce that Endovision Limited, a leading innovator in...
Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
First real-world dataset with integrated clinical and multiomic insights from 25,000 patients treated with GLP-1 therapies Dataset will advance development...
Carematix Urges Providers to Maximize 2025 PFS Revenue Potential by Shifting Medicare Patients to RPM+APCM from CCM
New Medicare Fee Schedule Creates Opportunity for PCPs, RHCs and FQHCs to Deliver Smarter, Scalable Remote Care with RPM and...
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives
$32.5 million funded at close; up to $17.5 million of additional capital available at the Company's option, subject to the...
Kids in Tech Announces Second Annual “Pathways to Success” Dinner & Awards
STEAM Nonprofit Celebrating Community Changemakers and Empowering Children with STEAM Opportunities LOWELL, Mass., May 1, 2025 /PRNewswire/ -- Kids in...
Identiv and InPlay Introduce Next-Generation BLE-Enabled Smart Labels for Industrial IoT Applications
Companies collaborate to develop high-performance, scalable BLE smart label portfolio for cold chain, logistics, and healthcare applications SANTA ANA, Calif....
Entos Pharmaceuticals (Entos) Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Edmonton, Alberta--(Newsfile Corp. - May 1, 2025) - Entos Pharmaceuticals (Entos), a clinical-stage genetic medicines company headquartered in Edmonton, Canada,...
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in...
Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL.
PALO ALTO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating...
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development – Oncology
Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across...
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing...
Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders
New patent covers a treatment method for a broad spectrum of alcohol-related disorders, including additional conditions associated with alcohol useGLEN...
Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and Efficacy Selected for Presentation at the 3rd Annual Precision Medicine in Inflammatory Bowel Disease Summit
Carlsbad, CA, May 01, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a...